COVID-19 vaccine equity: a health systems and policy perspective
- PMID: 34758678
- PMCID: PMC8631691
- DOI: 10.1080/14760584.2022.2004125
COVID-19 vaccine equity: a health systems and policy perspective
Abstract
Introduction: The global COVID-19 vaccine rollout has highlighted inequities in the accessibility of countries to COVID-19 vaccines. Populations in low- and middle-income countries have found it difficult to have access to COVID-19 vaccines.
Areas covered: This perspective provides analyses on historical and contemporary policy trends of vaccine development and immunization programs, including the current COVID-19 vaccination drive, and governance challenges. Moreover, we also provide a comparative health system analysis of the COVID-19 vaccine deployment in some countries from different continents. It recommends that the international Access to COVID-19 Tools Accelerator (ACT-A) partnership requires a strong governance mechanism and urgent financial investment.
Expert opinion: All WHO member states should agree on technology transfer and voluntary license-sharing via a commonly governed technology access pool and supported by a just Intellectual Property regime. Contextualized, dynamic understandings and country-specific versions of health systems strengthening are needed to improve vaccine equity in a sustainable matter.
Keywords: ACT-A; COVID-19 pandemic; TRIPS; Tanahashi health systems framework; capacity development; low-income countries; research & development ecosystem; technology transfer; vaccine equity.
References
-
- Randall T The world’s wealthiest countries are getting vaccinated 25 times faster.: bloomberg equality; 2021. [cited 2021 May 18]. Available from: https://www.bloomberg.com/news/articles/2021-04-09/when-will-world-be-fu...
-
- COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). [cited 2021 May 18]. Available from: https://coronavirus.jhu.edu/map.html
-
- World Health Organization . WHO SAGE roadmap for prioritizing the use of COVID-19 vaccines in the context of limited supply. 2020. [cited 2021 May 18]. Available from: https://www.who.int/docs/default-source/immunization/sage/covid/sage-pri...
-
- Reuters . Majority of Brazil COVID-19 ICU patients aged 40 years or younger - report. 2021. [cited 2021 May 18]. Available from: https://www.reuters.com/article/us-health-coronavirus-brazil-idUSKBN2C02UB
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical